Trading, could you clarify for me Leronlimab’s actual success rate? Your graphic seems to indicate that it worked for only about 1/3 of the patients (@300mg). We always hear about the numbers after 10 weeks (when most of the non-responders have already been identified and removed from the study). But these non-responding patients represent a much larger proportion of our potential customers than I had realized. Do you have comparable data for the percentage of non-responders at the higher doses? Many thanks in advance!